Randomized Trials Underway For Renal Denervation To Treat Hypertension
This article was originally published in The Gray Sheet
Ardian is moving forward with a prospective randomized clinical trial to study its Symplicity radiofrequency catheter for ablation of the sympathetic renal nerves to treat chronic hypertension, following successful results of its first-in-man study
You may also be interested in...
Ardian plans to introduce the first catheter-based treatment for uncontrolled hypertension in Europe by 2011 and in the U.S. by 2013
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.